Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03250975 · ClinicalTrials.gov registry record · Phase 1
Incidence of Acute Laryngeal Injury Following Endotracheal Intubation
A Phase 1 study of Intubation Complication, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- Phase 1
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT03250975: Active Phase 1 study of Intubation Complication, sponsored by Vanderbilt University Medical Center.
NCT03250975 is a Phase 1 study of Intubation Complication that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 64 participants, below the 26,547-participant average among 10 other Intubation Complication trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03250975, a Phase 1 study of Intubation Complication, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this investigation is to delineate the incidence of acute and chronic laryngeal injury following intubation within our health system. In addition, this study seeks to identify risk factors for airway injury that may provide information to help reduce the incidence of injury or increase the speed of diagnosis through hospital based process measures. Study Aims 1. Determine the incidence of acute laryngeal injury in patients with prolonged intubation. 2. Determine the incidence of chronic laryngeal injury in the subset of patients with acute laryngeal injury 3. Initiate a randomized control trial to investigate the ability of azithromycin and budesonide to improve objective and subjective breathing measures in patients with Acute Laryngeal injury (ALgI) following endotracheal intubation.
Primary Outcome
Endoscopic examination with evidence of laryngeal injury
Conditions Studied
Interventions
- DRUG Budesonide and Azithromycin
- OTHER Placebo control of budesonide and azithromycin
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2017-08-19 |
| Est. Completion | 2026-12-30 |
| Phase | Phase 1 |
What the registry record for NCT03250975 still lists
NCT03250975 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 26,547-participant average among 10 other Intubation Complication trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Intubation Complication appearing as the primary indexed condition, and to 2 interventions - of which Budesonide and Azithromycin is the first listed.
NCT03250975 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03250975 about?
NCT03250975 is a clinical study titled "Incidence of Acute Laryngeal Injury Following Endotracheal Intubation". The purpose of this investigation is to delineate the incidence of acute and chronic laryngeal injury following intubation within our health system. In addition, this study seeks to identify risk factors for airway injury that may provide information to help reduce the incidence of injury or increas...
What is the current status of trial NCT03250975?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 64 participants. The study started on 2017-08-19. Estimated completion is 2026-12-30.
What conditions does trial NCT03250975 study?
This clinical trial studies the following conditions: Intubation Complication.
What interventions are being tested in trial NCT03250975?
The interventions under investigation include: Budesonide and Azithromycin (DRUG), Placebo control of budesonide and azithromycin (OTHER).
Who is sponsoring clinical trial NCT03250975?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03250975 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intubation Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03250975's enrollment target sits among peer trials
64 9th of 10 higher than 2 of 10 other Intubation Complication trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intubation Complication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation
RECRUITING
-
Sonographic Assessment of Cricoid Pressure
RECRUITING · NA
-
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
RECRUITING · Phase 3
-
Optimizing Tracheal Intubation Outcomes and Neonatal Safety
RECRUITING · NA
-
The ED-AWARENESS-2 Trial
RECRUITING · NA
-
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI